Evaluating how atrial fibrosis affects atrial fibrillation risk in stroke patients
Official title: Impact of Atrial Fibrosis Surface Area on the Occurrence of Atrial Fibrillation in Patients With Ischemic Stroke of Undetermined Origin: a Prospective Cardiac MRI Pilot Study.
Run by Centre Hospitalier Universitaire Dijon · NCT06047782 · Data updated 2026-11-12
This study is trying to see if measuring heart tissue damage can help identify stroke patients who are at risk for developing atrial fibrillation and might benefit from better monitoring.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 157 (estimated) |
| Sponsor | Centre Hospitalier Universitaire Dijon Academic / other |
| Locations | 1 site (Dijon) |
| Status | Recruiting |
| Started | January 31, 2024 |
| Main results expected | January 2031 |
| Study ends | January 2031 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT06047782 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults who have experienced a cryptogenic ischemic stroke within the last 30 days and are scheduled for an implantable loop recorder.
✕Probably not a fit
Patients who have a history of atrial fibrillation or contraindications to MRI will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the relationship between the surface area of atrial fibrosis and the occurrence of atrial fibrillation in patients who have experienced an ischemic stroke of unknown origin. It utilizes cardiac MRI imaging to assess the left atrium and aims to improve the selection process for patients who may benefit from implantable loop recorders. By identifying patients at higher risk for atrial fibrillation, the study seeks to enhance long-term monitoring and treatment strategies. The study involves patients who have had a cryptogenic ischemic stroke within the last 30 days and are scheduled for loop recorder implantation.
Why it matters
Potential benefit: If successful, this study could lead to more targeted and effective monitoring of atrial fibrillation in stroke patients, potentially reducing the risk of future strokes.
How similar studies have gone: While the use of cardiac MRI in this context is innovative, similar studies have shown promise in identifying atrial fibrillation risk factors in stroke patients.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient who has provided free, written and informed consent * Patient of legal age * Patient with cryptogenic ischemic stroke within 30 days of inclusion, documented by brain imaging (cerebral angioscan or cerebral MRI) * Patients scheduled for implantable loop recorder implantation within 3 months of ischemic stroke in search of silent AF: * cryptogenic ischemic stroke or stroke with probable cardioembolic cause * no history of atrial fibrillation * no long-term anticoagulant therapy * with life expectancy \>12 months Exclusion Criteria: * Person not affiliated to national health insurance * Person under legal protection (curatorship, guardianship) * Person under court order * Pregnant, parturient or breast-feeding * Adult unable to give consent * Patient diagnosed with AF during stroke assessment * Patient with a contraindication to MRI or gadolinium injection: * Severe renal impairment (\<30ml/min Cockroft clearance due to gadolinium injection) * Claustrophobia / contraindication to MRI (metal implant not MRI compatible) * History of hypersensitivity to gadoteric acid or gadolinium-based contrast agents, and to meglumine * Uncontrolled asthma
Where it's running
-
Chu Dijon Bourgogne
Dijon, France Recruiting
Study contacts
- Study coordinator: Charles GUENANCIA
- Email: charles.guenancia@chu-dijon.fr
- Phone: 0380295623
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.